Vivos (RDGL) Consolidated Net Income (2010 - 2025)
Vivos (RDGL) reported Consolidated Net Income of -$1.1 million for Q4 2025, down 5.41% on a YoY basis from -$1.1 million in Q4 2024, and down 112.6% sequentially from -$507294.0 in Q3 2025.
Vivos (RDGL) Consolidated Net Income (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 16 years of Consolidated Net Income data on file, last reported at -$1.1 million in Q4 2025.
- For the quarter ending Q4 2025, Consolidated Net Income fell 5.41% year-over-year to -$1.1 million; the trailing twelve-month figure through Dec 2025 stood at -$3.1 million (down 5.35% YoY), and the FY2025 full-year result was -$3.1 million, down 5.35% from the prior year.
- Consolidated Net Income declined to -$1.1 million in Q4 2025, from -$507294.0 in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of -$178230.0 in Q4 2021 to a low of -$1.9 million in Q2 2021.
- A 5-year average of -$693457.2 and a median of -$683797.5 in 2022 frame the typical range for Consolidated Net Income.
- Across the five-year window, Consolidated Net Income sank 1069.29% in 2021 and jumped 64.52% in 2023, its largest moves.
- Tracing RDGL's Consolidated Net Income over 5 years: stood at -$178230.0 in 2021, then plunged by 295.92% to -$705653.0 in 2022, then slumped by 52.51% to -$1.1 million in 2023, then climbed by 4.93% to -$1.0 million in 2024, then fell by 5.41% to -$1.1 million in 2025.
- Business Quant data shows RDGL's Consolidated Net Income at -$1.1 million in Q4 2025, -$507294.0 in Q3 2025, and -$645513.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | -1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.08 Mn |
| Sep 30, 2025 | -507,294.00 |
| Jun 30, 2025 | -645,513.00 |
| Mar 31, 2025 | -834,696.00 |
| Dec 31, 2024 | -1.02 Mn |
| Sep 30, 2024 | -825,263.00 |
| Jun 30, 2024 | -503,458.00 |
| Mar 31, 2024 | -558,539.00 |
| Dec 31, 2023 | -1.08 Mn |
| Sep 30, 2023 | -667,690.00 |
| Jun 30, 2023 | -902,526.00 |
| Mar 31, 2023 | -248,318.00 |
| Dec 31, 2022 | -705,653.00 |
| Sep 30, 2022 | -277,065.00 |
| Jun 30, 2022 | -787,538.00 |
| Mar 31, 2022 | -699,905.00 |
| Dec 31, 2021 | -178,230.00 |
| Sep 30, 2021 | -201,160.00 |
| Jun 30, 2021 | -1.86 Mn |
| Mar 31, 2021 | -288,189.00 |